Archer-Daniels-Midland reported third quarter 2026 net earnings of $821 million, or $1.70 per share, alongside an adjusted EPS of $1.77. Driven by a constructive biofuels environment and strong operational execution, the company raised its full-year 2026 adjusted EPS outlook to a range of approximately $5.50 to $5.80.
Reported third quarter 2026 net earnings of $821 million, with adjusted net earnings of $858 million.
Raised full-year 2026 adjusted EPS guidance to approximately $5.50 to $5.80, up from the prior range of $5.15 to $5.60.
Total segment operating profit for the third quarter rose 64% year-over-year to $1.38 billion.
Capital expenditures for 2026 are now projected to be in the range of $1.2 to $1.3 billion, revised from the prior $1.3 to $1.5 billion range.
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
From Archer Daniels Midland's 10-Q and 10-K filings (SEC XBRL). YoY compares each quarter with the same quarter a year earlier; it is blank when the year-ago figure is missing or negative.
Annual results
Fiscal year
Revenue
Growth
EPS (diluted)
Growth
Net margin
FY2025
$24.96B
+2.4%
$2.23
-38.9%
4.3%
FY2024
$24.37B
-5.1%
$3.65
-43.2%
7.4%
FY2023
$25.69B
-6.9%
$6.43
-16.6%
13.6%
FY2022
$27.61B
-67.6%
$7.71
+61.0%
15.7%
FY2021
$85.25B
+32.5%
$4.79
+52.1%
3.2%
Frequently asked questions
When is Archer Daniels Midland's next earnings date?
Archer Daniels Midland has not announced a report date within the next three weeks. US companies usually report three to six weeks after each quarter ends; this page updates as soon as the date is on the calendar.
What did Archer Daniels Midland earn last quarter?
For the quarter ended Sep 2026, Archer Daniels Midland reported diluted EPS of $1.70 (+672.7% year over year) on revenue of $6.63B (+3.3%).
Where do these numbers come from?
Reported revenue, net income and EPS come from the company's own 10-Q and 10-K filings with the SEC (XBRL data). The report date and consensus estimate come from the Nasdaq earnings calendar.
Not investment advice. Figures can be restated by the company in later filings.